Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2020-12-04
Buyer: Oslo Universitetssykehus HF (hovedenhet)
Country: NO
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 33100000
Estimated value: 3544866 NOK
Award criteria: The most economic tender

Technical requirements: Avdeling for farmakologi ved Oslo universitetssykehus (the Department of Pharmacology at Oslo University Hospital), Rikshospitalet (the National Hospital of Norway) will procure UHPLC-MS/MS equipment (CE-IVD certified), which will be used for qualitative analysis of medicines, medicine metabolites and possibly biomarkers in biological sample material. The equipment will be used for laboratory diagnosis of patients and monitoring of treatment. The equipment must therefore be CE-IVD certified and be able to be used to achieve analyses with extremely good operational stability, selectivity, sensitivity, precision and accuracy.
Avdeling for farmakologi ved Oslo universitetssykehus (the Department of Pharmacology at Oslo University Hospital), Rikshospitalet (the National Hospital of Norway) will procure UHPLC-MS/MS equipment (CE-IVD certified), which will be used for qualitative analysis of medicines, medicine metabolites and possibly biomarkers in biological sample material. The equipment will be used for laboratory diagnosis of patients and monitoring of treatment. The equipment must therefore be CE-IVD certified and be able to be used to achieve analyses with extremely good operational stability, selectivity, sensitivity, precision and accuracy. The circulation time per sample on the instrument must be short and the capacity must be at least 25-30 000 samples per annum divided between at least 6 different analysis methods. It is a prerequisite that there are quick changes (flexibility) between analysis methods. In addition to routine quantification by MRM, the equipment must also be well suited to verify compliance (adherence). The mass spectrometer must therefore have extremely high sensitivity and have ion traps in order to carry out real MS3 for secure identification. In principle, the system be operable every day throughout the year (Monday-Sunday). All additional components that are necessary for the analysis equipment to be operative must be included in the procurement. Examples of relevant medicines that will be analysed: Methotrexate (low-dose and high-dose), Iohexol (measured GFR with Iohexol clearance), Statins (with metabolites), infectious agents (Linzolid, Ciproflaxacin, Merepenem, Tazobactam, Piperacillin, Cefotaxime, Ceftazidime, Ganciclovir), Imatinib, Tofacitinib, Baricitinib, 5-Fluorouracil, 5-Fluorocytosine.
Avdeling for farmakologi ved Oslo universitetssykehus (the Department of Pharmacology at Oslo University Hospital), Rikshospitalet (the National Hospital of Norway) will procure UHPLC-MS/MS equipment (CE-IVD certified), which will be used for qualitative analysis of medicines, medicine metabolites and possibly biomarkers in biological sample material. The equipment will be used for laboratory diagnosis of patients and monitoring of treatment. The equipment must therefore be CE-IVD certified and be able to be used to achieve analyses with extremely good operational stability, selectivity, sensitivity, precision and accuracy. The circulation time per sample on the instrument must be short and the capacity must be at least 25-30 000 samples per annum divided between at least 6 different analysis methods. It is a prerequisite that there are quick changes (flexibility) between analysis methods. In addition to routine quantification by MRM, the equipment must also be well suited to verify compliance (adherence). The mass spectrometer must therefore have extremely high sensitivity and have ion traps in order to carry out real MS3 for secure identification. In principle, the system be operable every day throughout the year (Monday-Sunday). All additional components that are necessary for the analysis equipment to be operative must be included in the procurement. Examples of relevant medicines that will be analysed: Methotrexate (low-dose and high-dose), Iohexol (measured GFR with Iohexol clearance),Statins (with metabolites), infectious agents (Linzolid, Ciproflaxacin, Merepenem, Tazobactam, Piperacillin, Cefotaxime, Ceftazidime, Ganciclovir), Imatinib, Tofacitinib, Baricitinib, 5-Fluorouracil, 5-Fluorocytosine.


Winner: AB Sciex AS
Award value: 3544866